Cite
MLA Citation
William J. Sandborn et al.. “Defining Remission Using Patient‐reported Outcome Components of the Crohn's Disease Activity Index: Post‐hoc Analyses of Vedolizumab Data from the GEMINI 2 Study.” American journal of gastroenterology, vol. 110, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100123027404.0x000044